TOP STORIES

• REGULATORY Leqembi Likely to Face 15% Price Cut Under Special CEA Rule
  July 10, 2025

• REGULATORY Pharma Groups Renew Push for Price Stability During Patent Term as FY2026 Reform Talks Begin
  July 10, 2025

• BUSINESS ASKA Targets 30% Overseas Sales Ratio through Southeast Asia Expansion: New President
  July 9, 2025

• REGULATORY AMED to Promote Earlier Out-Licensing to Industry to Bridge the “Devil’s River”: New Chief
  July 8, 2025

• REGULATORY Japan to Overhaul Diabetes Trial Guidelines to Align with Global Standards and Prevent Drug Lag/Loss
  July 7, 2025

• REGULATORY Healthcare-Linked Candidates Launch Campaigns as Upper House Election Gets Underway
  July 4, 2025

• COMMENTARY FY2024 Sees Divergence in I/O Drug Sales, Keytruda Thrives while Rivals Face Pricing Headwinds
  July 4, 2025

• BUSINESS Taking on Solid Tumors - 7: Astellas Aims for Global Lead in CLDN18.2 TCEs, Building on Success with Vyloy
  July 3, 2025

• REGULATORY Ex-Health Minister Takemi Vows to Bolster Japan’s Drug Development and Supply Resilience
  July 2, 2025

• REGULATORY LDP’s Honda Pledges Strong Support for Pharma Sector via Pro-Innovation Pricing and Supply Stabilization
  July 2, 2025

• BUSINESS Mitsubishi Tanabe to Rebrand as Tanabe Pharma after Bain Takeover
  July 2, 2025

• BUSINESS 17 of 23 Japan Drug Makers Hike Average Pay in FY2024, 7 Firms Break 10-Million-Yen Mark
  July 1, 2025

• REGULATORY MOF Poised to Discuss Use of CEA System with MHLW: Budget Examiner
  June 30, 2025

• REGULATORY Japan Launches Public-Private Council to Create Innovation Ecosystem
  June 27, 2025

• REGULATORY DPP’s Tamura Renews Call to Scrap Off-Year Drug Price Cuts, Urges Protection of On-Patent Prices
  June 26, 2025

• REGULATORY Japan Begins FY2026 Drug Pricing Reform Talks; Responses to Inflation, High-Cost Therapies on Agenda
  June 26, 2025

• REGULATORY Japan Approves MSD’s Airwin/Welireg, J&J Bispecific, and More
  June 25, 2025

• BUSINESS Aculys Moves Toward First Launch as It Tackles Japan’s Drug Lag/Loss
  June 24, 2025

• COMMENTARY Honebuto 2025 Approved - The Real Battle for Pharma Lies Ahead
  June 23, 2025

• ORGANIZATION JGA Targets FY2027 for Resolving Drug Shortages, Two Years Ahead of Forecast
  June 20, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• …
• Next ›
• 最終 »